1. Home
  2. CLX vs ILMN Comparison

CLX vs ILMN Comparison

Compare CLX & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clorox Company (The)

CLX

Clorox Company (The)

HOLD

Current Price

$101.18

Market Cap

12.7B

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$131.06

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLX
ILMN
Founded
1913
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.7B
20.5B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
CLX
ILMN
Price
$101.18
$131.06
Analyst Decision
Hold
Hold
Analyst Count
11
16
Target Price
$131.82
$117.31
AVG Volume (30 Days)
2.3M
1.5M
Earning Date
02-02-2026
02-05-2026
Dividend Yield
4.92%
N/A
EPS Growth
121.91
N/A
EPS
6.38
4.46
Revenue
$6,771,000,000.00
$4,288,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.80
$2.24
P/E Ratio
$15.80
$29.76
Revenue Growth
N/A
N/A
52 Week Low
$96.66
$68.70
52 Week High
$164.22
$153.06

Technical Indicators

Market Signals
Indicator
CLX
ILMN
Relative Strength Index (RSI) 46.68 51.81
Support Level $96.66 $132.93
Resistance Level $104.86 $135.95
Average True Range (ATR) 1.84 3.20
MACD 0.35 -0.93
Stochastic Oscillator 54.62 16.88

Price Performance

Historical Comparison
CLX
ILMN

About CLX Clorox Company (The)

Since its inception more than 100 years ago, Clorox has expanded to operate in a variety of consumer product categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration products, and natural personal care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. More than 80% of Clorox's sales come from its home turf.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: